Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Methylfolate Trap Promotes Bacterial Thymineless Death by Sulfa Drugs
Marissa B Guzzo1, Hoa T Nguyen1, Thanh H Pham1
1Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Abstract:
The methylfolate trap, a metabolic blockage associated with anemia, neural tube defects, Alzheimer's dementia, cardiovascular diseases, and cancer, was discovered in the 1960s, linking the metabolism of folate, vitamin B12, methionine and homocysteine. However, the existence or physiological significance of this phenomenon has been unknown in bacteria, which synthesize folate de novo. Here we identify the methylfolate trap as a novel determinant of the bacterial intrinsic death by sulfonamides, antibiotics that block de novo folate synthesis. Genetic mutagenesis, chemical complementation, and metabolomic profiling revealed trap-mediated metabolic imbalances, which induced thymineless death, a phenomenon in which rapidly growing cells succumb to thymine starvation. Restriction of B12 bioavailability, required for preventing trap formation, using an "antivitamin B12" molecule, sensitized intracellular bacteria to sulfonamides. Since boosting the bactericidal activity of sulfonamides through methylfolate trap induction can be achieved in Gram-negative bacteria and mycobacteria, it represents a novel strategy to render these pathogens more susceptible to existing sulfonamides.
Insights
The methylfolate trap, a metabolic issue, causes bacterial death when using sulfonamide antibiotics. Blocking vitamin B12 enhances this effect, offering a new strategy against bacterial infections.
Area of Science:
- Microbiology
- Biochemistry
- Genetics
Background:
- The methylfolate trap, a metabolic blockage linked to human diseases, was previously unstudied in bacteria.
- Bacteria synthesize folate de novo, making the relevance of the methylfolate trap unknown.
Purpose of the Study:
- To investigate the methylfolate trap's role in bacterial intrinsic death induced by sulfonamides.
- To explore the methylfolate trap as a potential target for enhancing antibiotic efficacy.
Main Methods:
- Genetic mutagenesis and chemical complementation were used to study metabolic pathways.
- Metabolomic profiling was employed to analyze metabolic imbalances.
- Antivitamin B12 molecules were used to restrict vitamin B12 bioavailability.
Main Results:
- The methylfolate trap was identified as a novel determinant of bacterial death by sulfonamides.
- Trap-mediated metabolic imbalances induced thymineless death (thymine starvation).
- Restricting vitamin B12 bioavailability sensitized bacteria to sulfonamides.
Conclusions:
- The methylfolate trap is a significant factor in bacterial susceptibility to sulfonamides.
- Inducing the methylfolate trap boosts sulfonamide bactericidal activity in Gram-negative bacteria and mycobacteria.
- Targeting the methylfolate trap presents a novel strategy to combat bacterial pathogens.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Sulfur Assimilation
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drugs that Destabilize Microtubules
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drugs that Stabilize Microtubules

